ArticleNeuro-oncology practice2022
Trends and outcomes of early and late palliative care consultation for adult patients with glioblastoma: A SEER-Medicare retrospective study.
Article in Neuro-oncology practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- SEER-Medicaid and SEER-Medicare data for neuro-oncology research.Journal of neuro-oncology · 2026Review
- Palliative care interventions and outcome in patients with glioblastoma - a retrospective, single-center study.BMC palliative care · 2026Article
- Article
- Early palliative care decision in patients with primary brain tumor reduces emergency department visits and hospitalization at the end of life.Journal of neuro-oncology · 2025Article
- From discovery to delivery: the spectrum of decisional supports for people with brain tumors.Neuro-oncology practice · 2025Article
- Contemporary Patterns of End-of-Life Care Among Medicare Beneficiaries With Advanced Cancer.JAMA health forum · 2025Article
- "Life…Gets Turned Upside-Down…" Opportunities to Improve Palliative Care for High-Grade Glioma.Journal of pain and symptom management · 2024Article
- Clinician perspectives on integrating neuro-oncology and palliative care for patients with high-grade glioma.Neuro-oncology practice · 2024Article
- Benchmarking palliative care practices in neurooncology: a german perspective.Journal of neuro-oncology · 2024Article
- Palliative care for in-patient malignant glioma patients in Germany.Journal of neuro-oncology · 2024Article
- Low expression of Ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status.Journal of neuro-oncology · 2023Observational
- Sonodynamic therapy and magnetic resonance-guided focused ultrasound: new therapeutic strategy in glioblastoma.Journal of neuro-oncology · 2023Review
- Palliative care referral across the disease trajectory in high-grade glioma.Journal of neuro-oncology · 2023Article
- Forecasting Molecular Features in IDH-Wildtype Gliomas: The State of the Art of Radiomics Applied to Neurosurgery.Cancers · 2023Review
- Palliative care implementation in neuro-oncology-Where do we come from, where do we go?Neuro-oncology practice · 2022Article
- Integrated early palliative care for patients with newly diagnosed glioblastoma: The GLIOSUPPORT feasibility study.Neuro-oncology advancesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Background: Glioblastoma (GBM) carries a poor prognosis despite standard of care. Early palliative care (PC) has been shown to enhance survival and quality of life while reducing healthcare costs for other cancers. This study investigates differences in PC timing on outcomes for patients with GBM. Methods: This study used Surveillance, Epidemiology, and End Results (SEER)-Medicare data from 1997 to 2016. Based on ICD codes, three groups were defined: (1) early PC within 10 weeks of diagnosis, (2) late PC, and (3) no PC. Outcomes were compared between the three groups. Results: Out of 10 812 patients with GBM, 1648 (15.24%) patients had PC consultation with an overall positive trend over time. There were no significant differences in patient characteristics. The late PC group had significantly higher number of hospice claims (1.06 ± 0.69) compared to those without PC, in the last month of life. There were significant differences in survival among the three groups ( Conclusion: We present the first investigation of PC consultation prevalence and outcomes, stratified by early versus late timing, for adult GBM patients. Despite an overall increase in PC consultations, only a minority of GBM patients receive PC. Patients with late PC had the longest survival times and had greater hospice use in the last month of life compared to other subgroups. Prospective studies can provide additional valuable information about this unique population of patients with GBM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.